Use of a United States-based laboratory as a hematopathology reference center for a developing country: logistics and results

Int J Lab Hematol. 2013 Feb;35(1):77-81. doi: 10.1111/ijlh.12001. Epub 2012 Sep 3.

Abstract

Introduction: With proper logistical support and sponsorship, a laboratory in an industrialized nation might be able to act as a reference laboratory for clinicians based in a developing country.

Methods: We built on previous experience in the clinical laboratory to see whether a specialized histopathology service (hematopathology) could be provided to a developing country without the expertise or experience to do it in country.

Results: Over an 13-year period, 582 cases from 579 individuals were analyzed. Principal pathologic findings included acute leukemia in 84 cases (14%), dyspoiesis in one or more of the hematopoietic lineages in 65 cases (11%, including three cases with high-grade myelodysplasia), 23 cases (4%) with findings suspicious for a chronic myeloproliferative disorder, 35 cases (6%) with findings suspicious for a lymphoproliferative disorder, and infectious organisms (presumably Leishmania in most instances) in 9 (1%) of cases. Specimens from 45 cases (8%) were unsatisfactory owing to extreme hemodilution and/or specimen degeneration.

Conclusion: With proper support, a medical laboratory in an industrialized nation may serve as a reference facility for a developing nation. The use of existing infrastructure may be remarkably effective to achieve optimal turnaround time. Although the lack of ancillary studies and follow-up biopsies limit the ability to achieve a definitive diagnosis in many cases, this must be viewed in the context of the limited ability to diagnose or manage hematopoietic neoplasia in developing nations.

MeSH terms

  • Aircraft
  • Bone Marrow / pathology
  • Bone Marrow Examination* / economics
  • Bone Marrow Examination* / standards
  • Developed Countries
  • Developing Countries
  • Eritrea
  • Health Care Costs
  • Hematologic Neoplasms / blood
  • Hematologic Neoplasms / diagnosis*
  • Hematologic Neoplasms / pathology
  • Hematologic Tests* / economics
  • Hematologic Tests* / standards
  • Hematology / economics
  • Hematology / methods
  • Hematology / organization & administration
  • Humans
  • Infectious Disease Medicine / economics
  • Infectious Disease Medicine / methods
  • Infectious Disease Medicine / organization & administration
  • International Agencies
  • International Cooperation*
  • Leishmaniasis / blood
  • Leishmaniasis / diagnosis*
  • Leishmaniasis / parasitology
  • Leishmaniasis / pathology
  • Medical Oncology / economics
  • Medical Oncology / methods
  • Medical Oncology / organization & administration
  • Pathology, Clinical / economics
  • Pathology, Clinical / methods
  • Pathology, Clinical / organization & administration
  • Specimen Handling
  • Telecommunications
  • Time Factors
  • United States
  • Voluntary Health Agencies